Cardiac sarcoidosis is an uncommon and frequently overlooked condition characterized by the formation of inflammatory granulomas within the heart tissue. This intricately connected aspect of sarcoidosis, a systemic inflammatory disorder impacting multiple organs, presents unique challenges when it involves the heart. The origin of cardiac sarcoidosis remains elusive, with suspicions pointing toward an abnormal immune response. Symptoms manifest diversely, ranging from arrhythmias and conduction abnormalities to heart failure. Pinpointing cardiac sarcoidosis necessitates a multifaceted diagnostic approach, incorporating clinical assessment and advanced imaging techniques such as cardiac MRI or PET scans, occasionally augmented by cardiac biopsy. Timely identification is paramount, given the potential for significant morbidity and mortality if left untreated. Treatment strategies typically involve immunosuppressive medications aimed at quelling inflammation and managing symptoms. In light of its rarity, fostering increased awareness and fostering collaborative efforts among healthcare professionals are imperative for enhancing early detection and effective management of cardiac sarcoidosis.
Title : Complete heart block and persistent left SVC: A pacing challenge after AV canal repair
Moataz Taha Mahmoud, Madinah Cardiac Center, Saudi Arabia
Title : Chemical detergent anionic surfactant-inducing dry cardiomyopathy (Yasser's cardiomyopathy) with parallel pupils/CXR phenomenon (Yasser's ophthalmic phenomenon), up-down Yasser's alternance, S1Q3 flat T3 pattern - Dramatic response to honey with possible cardiac regeneration - A case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt
Title : Stabilization of molecular structures in red blood cell membrane by magnetite nanoparticles (ICNB) during storage
Andrey Belousov, Laboratory of Applied Nanotechnology of Belousov and Kharkiv National Medical University, Ukraine